PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
|Articles|March 2, 2021
- Pharmaceutical Technology-03-02-2021
- Volume 45
- Issue 3
ROSS Inline High Shear Mixers
Inline high shear mixers from ROSS are available from 1 through 250 HP to accelerate mixing, emulsification, and homogenization in recirculation and continuous modes.
Inline high shear mixers from ROSS are available from 1 through 250 HP to accelerate mixing, emulsification, and homogenization in recirculation and continuous modes. The mixer can be used anywhere in a plant because of its mobile skid, eliminating the need for multiple mixers separately dedicated to each vessel or product.
The ROSS Model HSM-410 Inline High Shear Mixer (pictured) has the ability to handle applications with viscosities of up to 20,000 cP. A control panel may be mounted to the cart and wired to the mixer for complete portability. Additionally, 3A-approved sanitary models are available with tri-clamp inlet/outlet connections and a one-piece stator/chamber cover. Ultra-high shear mixer models are also available.
Articles in this issue
over 5 years ago
Genetic Vaccine Platforms Demonstrate Their Potentialover 5 years ago
Novel Excipients Needed More Than Ever Beforeover 5 years ago
Reviewing Recent Bioavailability Researchover 5 years ago
Digital Tools Enhance Raw Material Traceabilityover 5 years ago
Pandemic Spurs Cybersecurity Risks in Laboratoriesover 5 years ago
FDA Documents Achievements and Plans for Futureover 5 years ago
Adapting Regulations Post-BrexitRelated to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.